Abstract:Cardiovascular disease is the leading cause of mortality in the US. Studies suggest a role for environmental exposures in the etiology of cardiovascular disease, including exposure to arsenic through drinking water. Arsenic exposure during pregnancy has been shown to have effects on offspring, but few studies have examined impacts on maternal cardiovascular health. While our prior work documented the detrimental effect of arsenic on the maternal heart during pregnancy, our current study examines the effect of gestational arsenic exposure on the maternal heart postpartum. Timed-pregnant wild-type (C57BL/6J) mice were exposed to 0, 100 or 1000 µg/L sodium arsenite (NaAsO2) via drinking water from embryonic day 2.5 (E2.5) until parturition. Postpartum heart structure and function was assessed via transthoracic echocardiography and gravimetric measurement. Hypertrophic markers were probed via qRT-PCR and western blot. Isolated cardiomyocyte Ca 2+ -handling and contraction were also assessed, and expression of proteins associated with Ca 2+ handling and contraction. Interestingly, we found that exposure to either 100 or 1000 µg/L sodium arsenite increased postpartum heart size at P12 vs. non-exposed postpartum controls. At the cellular level, we found altered cardiomyocyte Ca 2+ -handling and contraction. We also found altered expression of key contractile proteins, including α-Actin and cardiac myosin binding protein C (cMyBP-c). Together, these findings suggest that gestational arsenic exposure impacts the postpartum maternal heart, possibly inducing long-term cardiovascular changes. Furthermore, these findings highlight the importance of reducing arsenic exposure during pregnancy, and the need for more research on the impact of arsenic and other environmental exposures on maternal heart health and adverse pregnancy events. New & noteworthy: Gestational exposure to sodium arsenite at environmentally relevant doses (100 and 1000 µg/L) increases postpartum heart size, and induces dysregulated Ca 2+ homeostasis and impaired shortening in isolated cardiomyocytes. This is the first study to demonstrate that gestational arsenic exposure impacts postpartum heart structure and function beyond the exposure period.

Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome

Health Effects Associated With Pre- and Perinatal Exposure to Arsenic

Arsenic Exposure During Juvenile and Puberty Significantly Affected Reproductive System Development of Female SD Rats

Prenatal arsenic exposure alters the placental expression of multiple epigenetic regulators in a sex-dependent manner

Prenatal Arsenic Exposure and Gene Expression in Fetal Liver, Heart, Lung, and Placenta

Impact of prenatal arsenic exposure on chronic adult diseases

Intergenerational arsenic exposure on the mouse epigenome and metabolic physiology

Transgenerational effects in DNA methylation, genotoxicity and reproductive phenotype by chronic arsenic exposure

Associations between area-level arsenic exposure and adverse birth outcomes: An Echo-wide cohort analysis

The impact of prenatal and early-life arsenic exposure on epigenetic age acceleration among adults in Northern Chile

Gestational arsenic exposure and paternal intergenerational epigenetic inheritance

Evidence of reduced gestational age in response to in utero arsenic exposure and implications for aging trajectories of the newborn

Gestational arsenite exposure alters maternal postpartum heart size and induces Ca2+ handling dysregulation in cardiomyocytes

Association between gestational arsenic exposure and infant physical development: a prospective cohort study

Prenatal Arsenic Exposure on DNA Methylation of C18ORF8 and ADAMTS9 Genes of Newborns from the POSGRAD Birth Cohort Study

Prenatal arsenic exposure, arsenic metabolism and neurocognitive development of 2-year-old children in low-arsenic areas

Association of arsenic exposure and clinical hematological changes during pregnancy: Findings from a prospective Wuhan birth cohort study

Biomonitoring of inorganic arsenic species in pregnancy

DNA methylation changes induced by prenatal toxic metal exposure: An overview of epidemiological evidence

Gestational arsenite exposure alters maternal postpartum heart size and induces Ca 2+ handling dysregulation in cardiomyocytes

Defining high confidence targets of differential CpG methylation in response to in utero arsenic exposure and implications for cancer risk